The role of IL-33 and IL-1β in the development of persistent allergic rhinitis in overweight/obese children
- Authors: Koroleva A.E.1, Bekezin V.V.1, Sergeeva I.N.2, Volkova E.A.3, Meshkova R.Y.1,4
-
Affiliations:
- Smolensk State Medical University
- Smolensk Regional Children’s Clinical Hospital
- Children’s Clinical Hospital
- Smolensk Clinical Hospital № 1
- Issue: Vol 19, No 4 (2022)
- Pages: 472-482
- Section: Original studies
- Submitted: 12.10.2022
- Accepted: 14.12.2022
- Published: 05.12.2022
- URL: https://rusalljournal.ru/raj/article/view/1575
- DOI: https://doi.org/10.36691/RJA1575
- ID: 1575
Cite item
Abstract
BACKGROUND: Few works were devoted to the study of the role of cytokines in children with allergic rhinitis (AR) with comorbid obesity.
AIMS: To study the level of cytokines interleukin (IL)1β, IL-33, IL-6, tumor necrosis factor (TNF)-α, and total IgE in the blood serum of overweight/obese children with intermittent and persistent AR.
MATERIALS AND METHODS: This cross-sectional observational study analyzed 69 children aged 7–10 years with AR in the remission period and was conducted from November 2020 to February 2021. All children went through a comprehensive examination for 3 days, including the definition of the serum concentrations IL-1β, IL-33, IL-6, TNF-α, and total IgE. Before blood sampling, children did not use nasal glucocorticosteroids, antileukotriene drugs for the last 4 weeks, and antihistamines for the last 7 days. Bioimpedansometry was used to assess the body weight by calculating the %FM (percentage of body fat mass).
RESULTS: The study included 44 children with AR and overweight/obesity (group I) and 25 children with AR and normal body weight (group II). The analysis of AR showed that in group I, intermittent AR was detected in 11 (25.0%) children (subgroup IA), whereas a persistent course was found in 33 children (75.0%) (subgroup IB). In group II, intermittent AR was detected in 13 (52.0%) children (subgroup IIA), whereas persistent AR in 12 children (48.0%) (subgroup IIB). The level of IL-1β in the blood serum was significantly higher in the subgroup IB than in subgroup IA (p=0.009). The concentration of IL-33 in children with persistent AR and obesity was significantly lower than that in children with intermittent AR and obesity (p=0.039). The level of IL-33 in the serum negatively correlated with %FM in group IA (r=-0.6673, p=0.035). The concentration of IL-1β negatively correlated with %FM in group IIB (r=-0,738, p=0,037). The levels of IL-6, TNF, and total IgE in obese children did not depend on the severity of AR.
CONCLUSIONS: The predictors of persistent AR in children with obesity are a decrease in the level of IL-33 and an increase in IL-1β in the blood serum. The negative correlation between the degree of obesity and IL-33 concentration in children with intermittent AR opens a window of opportunity for the personified management of children with AR and comorbid obesity.
Keywords
Full Text
About the authors
Anna E. Koroleva
Smolensk State Medical University
Author for correspondence.
Email: anna.ochkurenko@gmail.com
ORCID iD: 0000-0003-2655-1284
SPIN-code: 6007-1896
MD
Russian Federation, SmolenskVladimir V. Bekezin
Smolensk State Medical University
Email: smolenskbvv@yandex.ru
ORCID iD: 0000-0001-9141-5348
SPIN-code: 2518-3769
MD, Dr. Sci. (Med.), Professor
Russian Federation, SmolenskIrina N. Sergeeva
Smolensk Regional Children’s Clinical Hospital
Email: serg.irina72@mail.ru
ORCID iD: 0000-0001-8863-1103
Russian Federation, Smolensk
Elena A. Volkova
Children’s Clinical Hospital
Email: VL-71@yandex.ru
Russian Federation, Smolensk
Raisa Ya. Meshkova
Smolensk State Medical University; Smolensk Clinical Hospital № 1
Email: meshkova.raisa@yandex.ru
ORCID iD: 0000-0002-7806-9484
SPIN-code: 8937-1230
MD, Dr. Sci. (Med.), Professor
Russian Federation, Smolensk; SmolenskReferences
- Asher I, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537): 733–743. doi: 10.1016/S0140-6736(06)69283-0
- Liu Y, Sha J, Meng C, Zhu D. Mechanism of lower airway hyperresponsiveness induced by allergic rhinitis. J Immunol Res. 2022;2022:4351345. doi: 10.1155/2022/4351345
- Weinmayr G, Forastiere F, Büchele G, et al. Overweight/Obesity and respiratory and allergic disease in children: International study of asthma and allergies in childhood (ISAAC) phase two. PLoS One. 2014;9(12):e113996. doi: 10.1371/journal.pone.0113996
- Abarca-Gómez L, Abdeen ZA, Hamid ZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642. doi: 10.1016/S0140-6737(17)32129-3
- Peters U, Dixon AE, Forno E. Obesity and asthma. J Allergy Clin Immunol. 2018;141(4):1169–1179. doi: 10.1016/j.jaci.2018.02.004
- Umano GR, Pistone C, Tondina E, et al. Pediatric obesity and the immune system. Front. Pediatr. 2019;7:487. doi: 10.3389/fped.2019.00487
- Han MW, Kim SH, Oh I, et al. Obesity can contribute to severe persistent allergic rhinitis in children through leptin and interleukin-1β. Int Arch Allergy Immunol. 2021;182(6):546–552. doi: 10.1159/000512920
- Zeng Q, Luo X, Han M, et al. Leptin/Osteopontin axis regulated type 2t helper cell response in allergic rhinitis with obesity. EBio Medicine. 2018;(32):43–49. doi: 10.1016/j.ebiom.2018.05.037
- Zeyda M, Wernly B, Demyanets S, et al. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int J Obes (Lond). 2013;37(5):658–665. doi: 10.1038/ijo.2012.118
- Wang EW, Jia XS, Ruan CW, Ge ZR. miR-487b mitigates chronic heart failure through inhibition of the IL-33/ST2 signaling pathway. Oncotarget. 2017;8(31):51688–51702. doi: 10.18632/oncotarget.18393
- Zhou J, Luo F, Han Y, et al. Obesity/overweight and risk of allergic rhinitis: A meta-analysis of observational studies. Allergy Eur J Allergy Clinl Immunol. 2020;75(5):1272–1275. doi: 10.1111/all14143
- Sybilski AJ, Raciborski F, Lipiec A, et al. Obesity -- A risk factor for asthma, but not for atopic dermatitis, allergic rhinitis and sensitization. Public Health Nutr. 2015;18(3):530–536. doi: 10.1017/S1368980014000676
- Kelishadi R, Roufarshbaf M, Soheili S, et al. Association of childhood obesity and the immune system: A systematic review of reviews. Childhood Obesity. 2017;13(4):332–346. doi: 10.1089/сhi.2016.0176
- Fang X, Henao-Mejia J, Henrickson SE. Obesity and immune status in children. Current Opinion Pediatrics. 2020;32(6):805–815. doi: 10.1097/МОР0000000000000953
- Vehapoglu A, Cakın ZE, Kahraman FU, et al. Is overweight/obesity a risk factor for atopic allergic disease in prepubertal children? A case-control study. J Pediatric Endocrinol Metabolism. 2021;34(6):727–732. doi: 10.1515/jpem-2021-0051
- Han YY, Forno E, Gogna M, Celedón JC. Obesity and rhinitis in a nationwide study of children and adults in the United States. J Allergy Clin Immunol. 2016;137(5):1460–1465. doi: 10.1016/j.jaci.2015.12.1307
- Liu W, Zeng Q, Zhou L, et al. Association of leptin with disease severity and inflammation indicators in Chinese obese children with allergic rhinitis. Pediatric Allergy Immunol. 2018;29(2):186–193. doi: 10.1111/pai.12856
- Yazdi AS, Ghoreschi K. The interleukin-1 family. Adv Exp Med Biology. 2016;(941):21–29. doi: 10.1007/978-94-024-0921-5_2
- Han MW, Kim SH, Oh I, et al. Serum IL-1β can be a biomarker in children with severe persistent allergic rhinitis. Allergy Asthma Clin Immunol. 201;15(1):58. doi: 10.1186/s13223-019-0368-8
- De Oliveira, Talvani A, Rocha-Vieira E. IL-33 in obesity: where do we go from here? Inflamm Res. 2019;68(3):185–194. doi: 10.1007/s00011-019-01214-2
- Hasan A, Al-Ghimlas F, Warsame S, et al. IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects. BMC Immunol. 2014;15(1):19. doi: 10.1186/1471-2172-15-19
- Hong H, Liao S, Chen F, et al. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy. 2020;75(11):2794–2804. doi: 10.1111/all.14526
- Haenuki Y, Matsushita K, Futatsugi-Yumikura S, et al. A critical role of IL-33 in experimental allergic rhinitis. J Allergy Clin Immunol. 2012;130(1):184–194.e11. doi: 10.1016/j.jaci.2012.02.013
- Rogala B, Glück J. The role of interleukin-33 in rhinitis. Curr Allergy Asthma Rep. 2013;13(2):196–202. doi: 10.1007/s11882-013-0338-z
- Fan H, Qin TJ, Ye LS, et al. Expression of IL-25 and IL-33 and the count of EOS in peripheral blood of children with allergic rhinitis receiving immunotherapy. Lin Chung Er Bi. 2018;32(6):443–446. doi: 10.13201/j.issn.1001-1781.2018.06.011
- Sakashita M, Yoshimoto T, Hirota T, et al. Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clin Exp Allergy. 2008;38(12):1875–1881. doi: 10.1111/j.1365-2222.2008.03114.x